These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28443179)

  • 1. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.
    Shimada T
    Toxicol Res; 2017 Apr; 33(2):79-96. PubMed ID: 28443179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.
    Shimada T; Murayama N; Yamazaki H; Tanaka K; Takenaka S; Komori M; Kim D; Guengerich FP
    Chem Res Toxicol; 2013 Apr; 26(4):529-37. PubMed ID: 23432465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
    Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
    Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.
    Shimada T; Fujii-Kuriyama Y
    Cancer Sci; 2004 Jan; 95(1):1-6. PubMed ID: 14720319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
    Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
    Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
    Prokopczyk B; Rosa JG; Desai D; Amin S; Sohn OS; Fiala ES; El-Bayoumy K
    Cancer Lett; 2000 Dec; 161(1):35-46. PubMed ID: 11078911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.
    Shimada T; Takenaka S; Kakimoto K; Murayama N; Lim YR; Kim D; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2016 Jun; 29(6):1029-40. PubMed ID: 27137136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.
    Shimada T
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):257-76. PubMed ID: 16946553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.
    Shimada T; Kim D; Murayama N; Tanaka K; Takenaka S; Nagy LD; Folkman LM; Foroozesh MK; Komori M; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2013 Apr; 26(4):517-28. PubMed ID: 23432429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants.
    Shimada T; Murayama N; Kakimoto K; Takenaka S; Lim YR; Yeom S; Kim D; Yamazaki H; Guengerich FP; Komori M
    Xenobiotica; 2018 Jun; 48(6):565-575. PubMed ID: 28648140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
    Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
    Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1.
    Roos PH; Bolt HM
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):187-202. PubMed ID: 16922636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice.
    Shimada T; Sugie A; Yamada T; Kawazoe H; Hashimoto M; Azuma E; Nakajima T; Inoue K; Oda Y
    Xenobiotica; 2003 Sep; 33(9):957-71. PubMed ID: 14514444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.